Complexo Hospitalario Universitario de Ferrol
Centro de atención
Hospital Universitario Doctor Peset
Valencia, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Doctor Peset (26)
2024
-
Clinical and Epidemiological Characteristics of Patients Being Treated for Scabies in Spain: Opportunities for Improvement — A Multicenter Cross-Sectional CLINI-AEDV Study
Actas Dermo-Sifiliograficas, Vol. 115, Núm. 1, pp. 36-47
-
Spanish Society of Anesthesiology, Reanimation and Pain Therapy (SEDAR) Spanish Society of Emergency and Emergency Medicine (SEMES) and Spanish Society of Otolaryngology, Head and Neck Surgery (SEORL-CCC) Guideline for difficult airway management. Part I
Revista Espanola de Anestesiologia y Reanimacion, Vol. 71, Núm. 3, pp. 171-206
2023
-
Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193
-
Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients
British Journal of Surgery, Vol. 110, Núm. 12, pp. 1863-1876
-
The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain
Frontiers in Public Health, Vol. 11
2022
-
Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure
Seminars in Arthritis and Rheumatism, Vol. 52
-
Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 22, Núm. 6, pp. 941-953
-
Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications
Diabetes Therapy, Vol. 13, Núm. 5, pp. 873-888
-
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
Multiple Sclerosis and Related Disorders, Vol. 63
-
Early procalcitonin to predict mortality in critically ill COVID-19 patients: a multicentric cohort study
Minerva Anestesiologica, Vol. 88, Núm. 4, pp. 259-271
-
Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation
Acta Dermato-Venereologica, Vol. 102
-
Unmet needs in patients with moderate-to-severe plaque psoriasis treated with methotrexate in real world practice: FirST study
Journal of Dermatological Treatment, Vol. 33, Núm. 3, pp. 1329-1338
2021
-
Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation
BMC Cardiovascular Disorders, Vol. 21, Núm. 1
-
Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis
Scientific Reports, Vol. 11, Núm. 1
2019
-
Treatment of Type 2 Diabetes by Patient Profile in the Clinical Practice of Endocrinology in Spain: Delphi Study Results from the Think Twice Program
Diabetes Therapy, Vol. 10, Núm. 5, pp. 1893-1907
2017
-
Diagnostic Value and Validity of Early Spondyloarthritis Features: Results From a National Spanish Cohort
Arthritis Care and Research, Vol. 69, Núm. 6, pp. 938-942
2016
-
Characterization of patients with lupus nephritis included in a large cohort from the Spanish society of rheumatology registry of patients with systemic lupus erythematosus (RELESSER)
Medicine (United States), Vol. 95, Núm. 9
-
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study
BMC Cancer, Vol. 16, Núm. 1
-
Potential risk for inappropriate dyslipidemia screening in Primary Care in Spain
Revista del Laboratorio Clinico, Vol. 9, Núm. 2, pp. 48-53
-
Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry
Rheumatology (United Kingdom), Vol. 55, Núm. 7, pp. 1243-1250